Business Description
Realcan Pharmaceutical Group Co Ltd
NAICS : 325412
Compare
Compare
Traded in other countries / regions
002589.China IPO Date
2011-06-10Description
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.03 | |||||
| Equity-to-Asset | 0.29 | |||||
| Debt-to-Equity | 0.8 | |||||
| Debt-to-EBITDA | 10.12 | |||||
| Interest Coverage | 1.19 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.21 | |||||
| Beneish M-Score | -2.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -14.2 | |||||
| 3-Year EBITDA Growth Rate | -21 | |||||
| 3-Year EPS without NRI Growth Rate | -44.3 | |||||
| 3-Year FCF Growth Rate | 72.1 | |||||
| 3-Year Book Growth Rate | -3.7 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.01 | |||||
| 9-Day RSI | 27.81 | |||||
| 14-Day RSI | 33.66 | |||||
| 6-1 Month Momentum % | 9.74 | |||||
| 12-1 Month Momentum % | -0.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.21 | |||||
| Quick Ratio | 1.12 | |||||
| Cash Ratio | 0.38 | |||||
| Days Inventory | 57.14 | |||||
| Days Sales Outstanding | 253.07 | |||||
| Days Payable | 266.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.22 | |||||
| Dividend Payout Ratio | 0.19 | |||||
| 3-Year Dividend Growth Rate | -35.8 | |||||
| Forward Dividend Yield % | 0.22 | |||||
| 5-Year Yield-on-Cost % | 0.22 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 17.52 | |||||
| Operating Margin % | 3.66 | |||||
| Net Margin % | 0.47 | |||||
| ROE % | 0.9 | |||||
| ROA % | 0.25 | |||||
| ROIC % | 5.41 | |||||
| ROC (Joel Greenblatt) % | 14.5 | |||||
| ROCE % | 5.69 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 84.49 | |||||
| PE Ratio without NRI | 84.49 | |||||
| Shiller PE Ratio | 18.27 | |||||
| PS Ratio | 0.41 | |||||
| PB Ratio | 0.87 | |||||
| Price-to-Tangible-Book | 1.01 | |||||
| EV-to-EBIT | 10.51 | |||||
| EV-to-EBITDA | 10.51 | |||||
| EV-to-Revenue | 0.42 | |||||
| EV-to-FCF | -15.18 | |||||
| Price-to-Projected-FCF | 99.25 | |||||
| Price-to-Median-PS-Value | 0.54 | |||||
| Price-to-Graham-Number | 1.95 | |||||
| Price-to-Net-Current-Asset-Value | 4.09 | |||||
| Earnings Yield (Greenblatt) % | 9.46 | |||||
| Forward Rate of Return (Yacktman) % | -26.26 |
How Realcan Pharmaceutical Group Co Ltd (SZSE:002589) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Realcan Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 14,320.727 | ||
| EPS (TTM) (Â¥) | 0.047 | ||
| Beta | 0.72 | ||
| Volatility % | 54.36 | ||
| 14-Day RSI | 33.66 | ||
| 14-Day ATR (Â¥) | 0.066367 | ||
| 20-Day SMA (Â¥) | 4.0985 | ||
| 12-1 Month Momentum % | -0.93 | ||
| 52-Week Range (Â¥) | 3.36 - 6.73 | ||
| Shares Outstanding (Mil) | 1,504.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Realcan Pharmaceutical Group Co Ltd Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Realcan Pharmaceutical Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Realcan Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Realcan Pharmaceutical Group Co Ltd(SZSE:002589)'s stock price today?
The current price of SZSE:002589 is ¥3.97. The 52 week high of SZSE:002589 is ¥6.73 and 52 week low is ¥3.36.
When is next earnings date of Realcan Pharmaceutical Group Co Ltd(SZSE:002589)?
The next earnings date of Realcan Pharmaceutical Group Co Ltd(SZSE:002589) is .
Does Realcan Pharmaceutical Group Co Ltd(SZSE:002589) pay dividends? If so, how much?
The Dividend Yield %  of Realcan Pharmaceutical Group Co Ltd(SZSE:002589) is 0.22% (As of Today), Highest Dividend Payout Ratio of Realcan Pharmaceutical Group Co Ltd(SZSE:002589) was 0.2. The lowest was 0.04. And the median was 0.08. The  Forward Dividend Yield % of Realcan Pharmaceutical Group Co Ltd(SZSE:002589) is 0.22%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
